本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。
VHTの2023年Q1（3月）の配当金が発表されました。
2023年Q1（1月）の配当実績は$0.7586でした。（ブログ内で＄0.76と記載しています）
2022年Q1は0.722000（ブログ内では＄0.72と記載）だったので、前年同期比5.07％増配になりました。
一安心です。
増配率は以下のように計算できます。増配率 = （今年度配当金 – 前年度配当金）/ 前年度配当金
増配率 = （0.7586 – 0.7220）/ 0.7220 = 0.0507
増配率は約5.07％でした。
市場はS＆P500に優位に働いています
参考サイト
VHTの投資成績を詳しく知りたい人はバンガード社・Bloombergのウエイブサイトを参考にしてください。
Bloomberg.co.jp
VHT 銘柄 – ﾊﾞﾝｶﾞｰﾄﾞ･ﾍﾙｽｹｱETF 投資信託（ファンド）情報 日中および比較チャート、テクニカル分析、トレンドなどのﾊﾞﾝｶﾞｰﾄﾞ･ﾍﾙｽｹｱETF (VHT – ETF)の最新価格やパフォーマンスをご覧ください。
2023年Q1配当成績一覧表 あわせて読みたい
あわせて読みたい
VTの増配決定により、世界の株式市場が動く！2023年Q1の注目ポイントとは？ 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VTの2023年Q1（3月）の配当金が発表されました。 2023年Q1…
あわせて読みたい
2023年Q1のVYM配当：2023年以降も高配当ETFのトップランナーか？ 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VYMの2023年Q1（3月）の配当が発表されました。 2023年Q1…
あわせて読みたい
SPYD配当が前年度比-40.69％！高配当株ETFの落とし穴にはまらないために 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 SPYDの2023年Q1（3月）の配当金が発表されました。 2023年…
ぐりっとここからは2023年Q1をこれからも更新していきます。
目次
VHT概要
銘柄名：Vanguard Health Care ETF
銘柄構成数：414
運用会社：バンガード社
設定日：2004年1月26日
経費率：年率0.10％
配当利回り：1.46％（2022/9/27）
ベンチマーク：MSCI USインベスタブル・マーケット・ヘルスケア・インデックス
（MSCI US Investable Market Health Care 25/50 Index ）
・年初来リターン：-6.45％（2023/3/23）
構成銘柄
| 順位 | 構成銘柄 | 構成比率 |
| 1 | UnitedHealth Group Incorporated | 8.05% |
| 2 | Johnson & Johnson | 7.25% |
| 3 | AbbVie, Inc. | 4.92% |
| 4 | Merck & Co., Inc. | 4.87% |
| 5 | Eli Lilly and Company | 4.55% |
| 6 | Pfizer Inc. | 4.12% |
| 7 | Thermo Fisher Scientific Inc. | 3.84% |
| 8 | Abbott Laboratories | 3.21% |
| 9 | Danaher Corporation | 3.10% |
| 10 | Bristol-Myers Squibb Company | 2.65% |
| 11 | Amgen Inc. | 2.24% |
| 12 | Elevance Health, Inc. | 2.03% |
| 13 | Medtronic Plc | 1.99% |
| 14 | CVS Health Corporation | 1.99% |
| 15 | Gilead Sciences, Inc. | 1.74% |
| 16 | Stryker Corporation | 1.62% |
| 17 | Cigna Group | 1.62% |
| 18 | Regeneron Pharmaceuticals, Inc. | 1.47% |
| 19 | Intuitive Surgical, Inc. | 1.47% |
| 20 | Zoetis, Inc. Class A | 1.41% |
| 21 | Vertex Pharmaceuticals Incorporated | 1.35% |
| 22 | Boston Scientific Corporation | 1.21% |
| 23 | Becton, Dickinson and Company | 1.20% |
| 24 | Humana Inc. | 1.13% |
| 25 | HCA Healthcare Inc | 0.93% |
| 26 | Edwards Lifesciences Corporation | 0.90% |
| 27 | McKesson Corporation | 0.90% |
| 28 | Moderna, Inc. | 0.82% |
| 29 | DexCom, Inc. | 0.78% |
| 30 | Agilent Technologies, Inc. | 0.76% |
| 31 | IDEXX Laboratories, Inc. | 0.71% |
| 32 | Biogen Inc. | 0.70% |
| 33 | Centene Corporation | 0.70% |
| 34 | IQVIA Holdings Inc | 0.70% |
| 35 | Mettler-Toledo International Inc. | 0.58% |
| 36 | Illumina, Inc. | 0.57% |
| 37 | ResMed Inc. | 0.56% |
| 38 | GE Healthcare Technologies Inc. | 0.50% |
| 39 | Zimmer Biomet Holdings, Inc. | 0.47% |
| 40 | Seagen, Inc. | 0.45% |
| 41 | AmerisourceBergen Corporation | 0.43% |
| 42 | Horizon Therapeutics Public Limited Company | 0.43% |
| 43 | West Pharmaceutical Services, Inc. | 0.42% |
| 44 | Veeva Systems Inc Class A | 0.42% |
| 45 | Align Technology, Inc. | 0.42% |
| 46 | Alnylam Pharmaceuticals, Inc | 0.40% |
| 47 | Laboratory Corporation of America Holdings | 0.38% |
| 48 | Baxter International Inc. | 0.36% |
| 49 | Cardinal Health, Inc. | 0.36% |
| 50 | Hologic, Inc. | 0.35% |
| 51 | Insulet Corporation | 0.35% |
| 52 | STERIS Plc | 0.34% |
| 53 | BioMarin Pharmaceutical Inc. | 0.33% |
| 54 | Waters Corporation | 0.33% |
| 55 | Avantor, Inc. | 0.30% |
| 56 | Cooper Companies, Inc. | 0.29% |
| 57 | Molina Healthcare, Inc. | 0.29% |
| 58 | Quest Diagnostics Incorporated | 0.29% |
| 59 | PerkinElmer, Inc. | 0.28% |
| 60 | Incyte Corporation | 0.26% |
| 61 | Viatris, Inc. | 0.25% |
| 62 | Royalty Pharma Plc Class A | 0.23% |
| 63 | U.S. Dollar | 0.22% |
| 64 | Catalent Inc | 0.21% |
| 65 | Bio-Techne Corporation | 0.21% |
| 66 | United Therapeutics Corporation | 0.20% |
| 67 | Teleflex Incorporated | 0.20% |
| 68 | Charles River Laboratories International, Inc. | 0.20% |
| 69 | Exact Sciences Corporation | 0.20% |
| 70 | Bio-Rad Laboratories, Inc. Class A | 0.19% |
| 71 | Henry Schein, Inc. | 0.19% |
| 72 | Neurocrine Biosciences, Inc. | 0.18% |
| 73 | Sarepta Therapeutics, Inc. | 0.17% |
| 74 | Penumbra, Inc. | 0.17% |
| 75 | Repligen Corporation | 0.17% |
| 76 | Jazz Pharmaceuticals Public Limited Company | 0.16% |
| 77 | Universal Health Services, Inc. Class B | 0.16% |
| 78 | Masimo Corporation | 0.15% |
| 79 | DENTSPLY SIRONA, Inc. | 0.15% |
| 80 | Chemed Corporation | 0.14% |
| 81 | Inspire Medical Systems, Inc. | 0.14% |
| 82 | NovoCure Ltd. | 0.13% |
| 83 | Bruker Corporation | 0.13% |
| 84 | Shockwave Medical, Inc. | 0.12% |
| 85 | Acadia Healthcare Company, Inc. | 0.12% |
| 86 | Halozyme Therapeutics, Inc. | 0.12% |
| 87 | Envista Holdings Corp. | 0.11% |
| 88 | Organon & Co. | 0.11% |
| 89 | Tenet Healthcare Corporation | 0.11% |
| 90 | Apellis Pharmaceuticals, Inc. | 0.10% |
| 91 | Encompass Health Corporation | 0.10% |
| 92 | HealthEquity Inc | 0.10% |
| 93 | Exelixis, Inc. | 0.10% |
| 94 | Karuna Therapeutics, Inc. | 0.10% |
| 95 | Lantheus Holdings Inc | 0.09% |
| 96 | Perrigo Co. Plc | 0.09% |
| 97 | Natera, Inc. | 0.09% |
| 98 | Elanco Animal Health, Inc. | 0.09% |
| 99 | Medpace Holdings, Inc. | 0.09% |
| 100 | Ensign Group, Inc. | 0.09% |
| 101 | Ionis Pharmaceuticals, Inc. | 0.08% |
| 102 | Globus Medical Inc Class A | 0.08% |
| 103 | Option Care Health Inc | 0.08% |
| 104 | DaVita Inc. | 0.08% |
| 105 | Alkermes Public Limited Company | 0.08% |
| 106 | agilon health inc | 0.08% |
| 107 | QuidelOrtho Corporation | 0.08% |
| 108 | Teladoc Health, Inc. | 0.08% |
| 109 | Integra LifeSciences Holdings Corporation | 0.08% |
| 110 | Intra-Cellular Therapies, Inc. | 0.08% |
| 111 | Syneos Health, Inc. Class A | 0.08% |
| 112 | Merit Medical Systems, Inc. | 0.07% |
| 113 | Haemonetics Corporation | 0.07% |
| 114 | AMN Healthcare Services, Inc. | 0.07% |
| 115 | Cytokinetics, Incorporated | 0.07% |
| 116 | Oak Street Health, Inc. | 0.07% |
| 117 | Neogen Corp | 0.07% |
| 118 | Premier, Inc. Class A | 0.07% |
| 119 | CRISPR Therapeutics AG | 0.07% |
| 120 | 10x Genomics Inc Class A | 0.07% |
| 121 | iRhythm Technologies, Inc. | 0.06% |
| 122 | ICU Medical, Inc. | 0.06% |
| 123 | Azenta, Inc. | 0.06% |
| 124 | Arrowhead Pharmaceuticals, Inc. | 0.06% |
| 125 | Madrigal Pharmaceuticals, Inc. | 0.06% |
| 126 | Doximity, Inc. Class A | 0.06% |
| 127 | Evolent Health Inc Class A | 0.05% |
| 128 | Guardant Health, Inc. | 0.05% |
| 129 | Amedisys, Inc. | 0.05% |
| 130 | Prestige Consumer Healthcare Inc | 0.05% |
| 131 | Ultragenyx Pharmaceutical, Inc. | 0.05% |
| 132 | CONMED Corporation | 0.05% |
| 133 | Select Medical Holdings Corporation | 0.05% |
| 134 | Revance Therapeutics, Inc. | 0.05% |
| 135 | Prometheus Biosciences, Inc | 0.05% |
| 136 | Intellia Therapeutics, Inc. | 0.05% |
| 137 | PTC Therapeutics, Inc. | 0.05% |
| 138 | Enovis Corporation | 0.05% |
| 139 | Progyny, Inc. | 0.05% |
| 140 | Amicus Therapeutics, Inc. | 0.05% |
| 141 | Insmed Incorporated | 0.05% |
| 142 | Denali Therapeutics Inc. | 0.05% |
| 143 | Blueprint Medicines Corp. | 0.05% |
| 144 | LivaNova Plc | 0.05% |
| 145 | ACADIA Pharmaceuticals Inc. | 0.05% |
| 146 | Integer Holdings Corporation | 0.04% |
| 147 | Omnicell, Inc. | 0.04% |
| 148 | TransMedics Group, Inc. | 0.04% |
| 149 | Inari Medical, Inc. | 0.04% |
| 150 | Axonics, Inc. | 0.04% |
| 151 | IVERIC bio, Inc. | 0.04% |
| 152 | Patterson Companies Incorporated | 0.04% |
| 153 | Tandem Diabetes Care, Inc. | 0.04% |
| 154 | STAAR Surgical Company | 0.04% |
| 155 | Vaxcyte, Inc. | 0.04% |
| 156 | Beam Therapeutics, Inc. | 0.04% |
| 157 | NuVasive, Inc. | 0.04% |
| 158 | Glaukos Corp | 0.04% |
| 159 | Surgery Partners, Inc. | 0.04% |
| 160 | Privia Health Group, Inc. | 0.04% |
| 161 | SAGE Therapeutics, Inc. | 0.04% |
| 162 | Axsome Therapeutics, Inc. | 0.04% |
| 163 | TG Therapeutics, Inc. | 0.04% |
| 164 | R1 RCM Inc | 0.04% |
| 165 | Signify Health, Inc. Class A | 0.04% |
| 166 | Supernus Pharmaceuticals, Inc. | 0.04% |
| 167 | NeoGenomics, Inc. | 0.04% |
| 168 | Silk Road Medical, Inc. | 0.04% |
| 169 | Corcept Therapeutics Incorporated. | 0.04% |
| 170 | FibroGen, Inc. | 0.04% |
| 171 | Pacira Biosciences, Inc. | 0.04% |
| 172 | Pacific Biosciences of California, Inc. | 0.04% |
| 173 | Prothena Corp. Plc | 0.03% |
| 174 | Certara, Inc. | 0.03% |
| 175 | Xenon Pharmaceuticals Inc. | 0.03% |
| 176 | Mirati Therapeutics Inc. | 0.03% |
| 177 | Embecta Corporation | 0.03% |
| 178 | Xencor, Inc. | 0.03% |
| 179 | Phreesia, Inc. | 0.03% |
| 180 | Veradigm Inc. | 0.03% |
| 181 | Veracyte Inc | 0.03% |
| 182 | Addus HomeCare Corporation | 0.03% |
| 183 | Tilray Brands, Inc. | 0.03% |
| 184 | CorVel Corporation | 0.03% |
| 185 | AtriCure, Inc. | 0.03% |
| 186 | Vir Biotechnology, Inc. | 0.03% |
| 187 | Cerevel Therapeutics Holdings Inc | 0.03% |
| 188 | Revolution Medicines, Inc. | 0.03% |
| 189 | BioCryst Pharmaceuticals, Inc. | 0.03% |
| 190 | Sotera Health Company | 0.03% |
| 191 | Maravai Lifesciences Holdings, Inc. Class A | 0.03% |
| 192 | Celldex Therapeutics, Inc. | 0.03% |
| 193 | Ironwood Pharmaceuticals, Inc. Class A | 0.03% |
| 194 | Myriad Genetics, Inc. | 0.03% |
| 195 | Catalyst Pharmaceuticals, Inc. | 0.03% |
| 196 | Krystal Biotech, Inc. | 0.03% |
| 197 | Establishment Labs Holdings, Inc. | 0.03% |
| 198 | Arvinas, Inc. | 0.03% |
| 199 | Akero Therapeutics, Inc. | 0.03% |
| 200 | Apollo Medical Holdings, Inc. | 0.02% |
| 201 | Pliant Therapeutics, Inc. | 0.02% |
| 202 | Syndax Pharmaceuticals Inc | 0.02% |
| 203 | Hims & Hers Health, Inc. Class A | 0.02% |
| 204 | MannKind Corporation | 0.02% |
| 205 | U.S. Physical Therapy, Inc. | 0.02% |
| 206 | Avanos Medical, Inc. | 0.02% |
| 207 | Vericel Corporation | 0.02% |
| 208 | Schrodinger, Inc. | 0.02% |
| 209 | Relay Therapeutics, Inc. | 0.02% |
| 210 | Avidity Biosciences Inc | 0.02% |
| 211 | Agios Pharmaceuticals, Inc. | 0.02% |
| 212 | Dynavax Technologies Corporation | 0.02% |
| 213 | ModivCare Inc. | 0.02% |
| 214 | Pediatrix Medical Group, Inc. | 0.02% |
| 215 | Amphastar Pharmaceuticals, Inc. | 0.02% |
| 216 | Ligand Pharmaceuticals Incorporated | 0.02% |
| 217 | RadNet, Inc. | 0.02% |
| 218 | Travere Therapeutics, Inc. | 0.02% |
| 219 | Myovant Sciences Ltd. | 0.02% |
| 220 | Rocket Pharmaceuticals, Inc. | 0.02% |
| 221 | Kymera Therapeutics, Inc. | 0.02% |
| 222 | Owens & Minor, Inc. | 0.02% |
| 223 | Aurinia Pharmaceuticals Inc. | 0.02% |
| 224 | Rhythm Pharmaceuticals, Inc. | 0.02% |
| 225 | Springworks Therapeutics, Inc. | 0.02% |
| 226 | Alphatec Holdings, Inc. | 0.02% |
| 227 | AdaptHealth Corp. | 0.02% |
| 228 | CryoPort, Inc. | 0.02% |
| 229 | Nevro Corp. | 0.02% |
| 230 | Twist Bioscience Corp. | 0.02% |
| 231 | Harmony Biosciences Holdings, Inc. | 0.02% |
| 232 | NextGen Healthcare, Inc. | 0.02% |
| 233 | Avid Bioservices, Inc. | 0.02% |
| 234 | Viridian Therapeutics, Inc. | 0.02% |
| 235 | LeMaitre Vascular, Inc. | 0.02% |
| 236 | Cassava Sciences, Inc. | 0.02% |
| 237 | Enanta Pharmaceuticals, Inc. | 0.02% |
| 238 | Mesa Laboratories, Inc. | 0.02% |
| 239 | Cross Country Healthcare, Inc. | 0.02% |
| 240 | Outset Medical, Inc. | 0.02% |
| 241 | DICE Therapeutics, Inc. | 0.02% |
| 242 | Chinook Therapeutics Inc | 0.02% |
| 243 | Morphic Holding, Inc. | 0.02% |
| 244 | CareDx, Inc. | 0.02% |
| 245 | Keros Therapeutics, Inc. | 0.02% |
| 246 | uniQure N.V. | 0.02% |
| 247 | Zentalis Pharmaceuticals, Inc. | 0.02% |
| 248 | Adaptive Biotechnologies Corp. | 0.02% |
| 249 | Iovance Biotherapeutics Inc | 0.02% |
| 250 | RAPT Therapeutics, Inc. | 0.02% |
| 251 | Collegium Pharmaceutical, Inc. | 0.02% |
| 252 | Alignment Healthcare, Inc. | 0.02% |
| 253 | Reata Pharmaceuticals, Inc. Class A | 0.02% |
| 254 | Heska Corporation | 0.02% |
| 255 | REGENXBIO, Inc. | 0.01% |
| 256 | Cardiovascular Systems, Inc. | 0.01% |
| 257 | Atrion Corporation | 0.01% |
| 258 | National HealthCare Corporation | 0.01% |
| 259 | Replimune Group, Inc. | 0.01% |
| 260 | Arcus Biosciences, Inc. | 0.01% |
| 261 | ImmunoGen, Inc. | 0.01% |
| 262 | BridgeBio Pharma, Inc. | 0.01% |
| 263 | Enhabit, Inc | 0.01% |
| 264 | Deciphera Pharmaceuticals, Inc. | 0.01% |
| 265 | DocGo Inc. | 0.01% |
| 266 | Innoviva, Inc. | 0.01% |
| 267 | BioLife Solutions, Inc. | 0.01% |
| 268 | Anavex Life Sciences Corp. | 0.01% |
| 269 | Community Health Systems, Inc. | 0.01% |
| 270 | Crinetics Pharmaceuticals Inc | 0.01% |
| 271 | Ventyx Biosciences, Inc. | 0.01% |
| 272 | Novavax, Inc. | 0.01% |
| 273 | Varex Imaging Corporation | 0.01% |
| 274 | Intercept Pharmaceuticals, Inc. | 0.01% |
| 275 | OrthoPediatrics Corp. | 0.01% |
| 276 | Nuvalent, Inc. Class A | 0.01% |
| 277 | Arcutis Biotherapeutics Inc | 0.01% |
| 278 | ADMA Biologics, Inc. | 0.01% |
| 279 | Cytek Biosciences, Inc. | 0.01% |
| 280 | Kura Oncology, Inc. | 0.01% |
| 281 | Orthofix Medical, Inc. | 0.01% |
| 282 | Health Catalyst, Inc. | 0.01% |
| 283 | Accolade, Inc. | 0.01% |
| 284 | 23andMe Holding Co. Class A | 0.01% |
| 285 | Immunovant Inc | 0.01% |
| 286 | FIGS, Inc. Class A | 0.01% |
| 287 | Verve Therapeutics, Inc. | 0.01% |
| 288 | Agiliti, Inc. | 0.01% |
| 289 | Inhibrx Inc | 0.01% |
| 290 | Fulgent Genetics, Inc. | 0.01% |
| 291 | HealthStream, Inc. | 0.01% |
| 292 | Simulations Plus, Inc. | 0.01% |
| 293 | Editas Medicine, Inc. | 0.01% |
| 294 | Altimmune, Inc. | 0.01% |
| 295 | Protagonist Therapeutics, Inc. | 0.01% |
| 296 | ViewRay, Inc. | 0.01% |
| 297 | Aclaris Therapeutics, Inc. | 0.01% |
| 298 | SI-BONE, Inc. | 0.01% |
| 299 | OPKO Health, Inc. | 0.01% |
| 300 | American Well Corporation Class A | 0.01% |
| 301 | Merus N.V. | 0.01% |
| 302 | Agenus Inc. | 0.01% |
| 303 | Castle Biosciences, Inc. | 0.01% |
| 304 | Emergent BioSolutions Inc. | 0.01% |
| 305 | Allogene Therapeutics, Inc. | 0.01% |
| 306 | Theravance Biopharma Inc | 0.01% |
| 307 | Brookdale Senior Living Inc. | 0.01% |
| 308 | Artivion, Inc. | 0.01% |
| 309 | Cutera, Inc. | 0.01% |
| 310 | Cerus Corporation | 0.01% |
| 311 | Seres Therapeutics Inc | 0.01% |
| 312 | Invitae Corp. | 0.01% |
| 313 | AngioDynamics, Inc. | 0.01% |
| 314 | EQUITY OTHER | 0.01% |
| 315 | 2seventy Bio, Inc. | 0.01% |
| 316 | POINT Biopharma Global Inc. | 0.01% |
| 317 | Paragon 28, Inc. | 0.01% |
| 318 | Senseonics Holdings, Inc. | 0.01% |
| 319 | Fate Therapeutics, Inc. | 0.01% |
| 320 | Cara Therapeutics Inc | 0.01% |
| 321 | Alector, Inc. | 0.01% |
| 322 | Cogent Biosciences, Inc. | 0.01% |
| 323 | Recursion Pharmaceuticals, Inc. Class A | 0.01% |
| 324 | OraSure Technologies, Inc. | 0.01% |
| 325 | Clover Health Investments Corp. Class A | 0.01% |
| 326 | NanoString Technologies, Inc. | 0.01% |
| 327 | Arcellx, Inc. | 0.01% |
| 328 | Coherus BioSciences, Inc. | 0.01% |
| 329 | Sangamo Therapeutics, Inc. | 0.01% |
| 330 | AnaptysBio, Inc. | 0.01% |
| 331 | Pennant Group Inc | 0.01% |
| 332 | PROCEPT BioRobotics Corp. | 0.01% |
| 333 | Definitive Healthcare Corp. Class A | 0.01% |
| 334 | Kiniksa Pharmaceuticals Ltd. Class A | 0.01% |
| 335 | Bionano Genomics, Inc. | 0.01% |
| 336 | Quanterix Corporation | 0.01% |
| 337 | Arcturus Therapeutics Holdings, Inc. | 0.01% |
| 338 | GoodRx Holdings, Inc. Class A | 0.01% |
| 339 | MiMedx Group, Inc. | 0.01% |
| 340 | OmniAb, Inc. | 0.01% |
| 341 | SomaLogic, Inc. Class A | 0.01% |
| 342 | Vanda Pharmaceuticals Inc. | 0.01% |
| 343 | Treace Medical Concepts, Inc. | 0.01% |
| 344 | Inogen, Inc. | 0.01% |
| 345 | iTeos Therapeutics, Inc. | 0.01% |
| 346 | EQRx, Inc. | 0.01% |
| 347 | Nurix Therapeutics, Inc. | 0.01% |
| 348 | Eagle Pharmaceuticals, Inc. | 0.01% |
| 349 | Atara Biotherapeutics Inc | 0.01% |
| 350 | MaxCyte, Inc. | 0.01% |
| 351 | Phibro Animal Health Corporation Class A | 0.01% |
| 352 | Sana Biotechnology, Inc. | 0.01% |
| 353 | Pulmonx Corp. | 0.01% |
| 354 | Inovio Pharmaceuticals, Inc. | 0.01% |
| 355 | OptimizeRx Corporation | 0.01% |
| 356 | SIGA Technologies Inc | 0.01% |
| 357 | SurModics, Inc. | 0.01% |
| 358 | MacroGenics, Inc. | 0.01% |
| 359 | ImmunityBio Inc | 0.01% |
| 360 | CareMax, Inc. Class A | 0.01% |
| 361 | Heron Therapeutics Inc | 0.01% |
| 362 | Cano Health, Inc. Class A | 0.01% |
| 363 | Codexis, Inc. | 0.01% |
| 364 | Butterfly Network, Inc. Class A | 0.01% |
| 365 | Tarsus Pharmaceuticals, Inc. | 0.00% |
| 366 | MeiraGTx Holdings Plc | 0.00% |
| 367 | Atea Pharmaceuticals, Inc. | 0.00% |
| 368 | Nektar Therapeutics | 0.00% |
| 369 | Rigel Pharmaceuticals, Inc. | 0.00% |
| 370 | Tango Therapeutics, Inc. | 0.00% |
| 371 | Erasca, Inc. | 0.00% |
| 372 | PetIQ, Inc. Class A | 0.00% |
| 373 | Fulcrum Therapeutics, Inc. | 0.00% |
| 374 | ZimVie Inc. | 0.00% |
| 375 | Nuvation Bio, Inc. Class A | 0.00% |
| 376 | Joint Corp. | 0.00% |
| 377 | IGM Biosciences, Inc. | 0.00% |
| 378 | ATAI Life Sciences N.V. | 0.00% |
| 379 | Ocugen Inc | 0.00% |
| 380 | Aerovate Therapeutics, Inc. | 0.00% |
| 381 | Janux Therapeutics, Inc. | 0.00% |
| 382 | Amneal Pharmaceuticals, Inc. Class A | 0.00% |
| 383 | MultiPlan Corp Class A | 0.00% |
| 384 | Repare Therapeutics Inc. | 0.00% |
| 385 | Quantum-Si Incorporated Class A | 0.00% |
| 386 | HilleVax, Inc | 0.00% |
| 387 | Humacyte, Inc. | 0.00% |
| 388 | Phathom Pharmaceuticals, Inc. | 0.00% |
| 389 | Cullinan Oncology, Inc. | 0.00% |
| 390 | Seer, Inc. Class A | 0.00% |
| 391 | Adicet Bio Inc | 0.00% |
| 392 | Akoya Biosciences Inc | 0.00% |
| 393 | PMV Pharmaceuticals, Inc. | 0.00% |
| 394 | Organogenesis Holdings, Inc. Class A | 0.00% |
| 395 | Entrada Therapeutics Inc | 0.00% |
| 396 | Stoke Therapeutics, Inc. | 0.00% |
| 397 | NGM Biopharmaceuticals, Inc. | 0.00% |
| 398 | Y-mAbs Therapeutics, Inc. | 0.00% |
| 399 | ALX Oncology Holdings, Inc. | 0.00% |
| 400 | Foghorn Therapeutics, Inc. | 0.00% |
| 401 | PDL BioPharma, Inc. | 0.00% |
| 402 | Monte Rosa Therapeutics, Inc. | 0.00% |
| 403 | Gossamer Bio, Inc. | 0.00% |
| 404 | Vaxart, Inc. | 0.00% |
| 405 | Century Therapeutics, Inc. | 0.00% |
| 406 | Nautilus Biotechnolgy, Inc. | 0.00% |
| 407 | Aveanna Healthcare Holdings Inc | 0.00% |
| 408 | Vanguard Cash Management Market Liquidity Fund | 0.00% |
| 409 | Akoya Biosciences Inc | 0.00% |
| 410 | Nautilus Biotechnolgy, Inc. | 0.00% |
| 411 | Sema4 Holdings Corp. Class A | 0.00% |
| 412 | Aveanna Healthcare Holdings Inc | 0.00% |
| 413 | Vanguard Cash Management Market Liquidity Fund | 0.00% |
| 414 | EQUITY OTHER | 0.00% |
VHTチャート・配当金・配当利回り
配当金
| 西暦 | Q1 | Q2 | Q3 | Q4 | Annual | 増配率 |
| 2004 | $0.00 | $0.00 | $0.00 | $0.13 | $0.13 | – |
| 2005 | $0.00 | $0.00 | $0.00 | $0.39 | $0.39 | 200.0% |
| 2006 | $0.00 | $0.00 | $0.00 | $0.62 | $0.62 | 59.0% |
| 2007 | $0.00 | $0.00 | $0.00 | $0.82 | $0.82 | 32.3% |
| 2008 | $0.00 | $0.00 | $0.00 | $0.75 | $0.75 | -8.5% |
| 2009 | $0.00 | $0.00 | $0.00 | $1.49 | $1.49 | 98.7% |
| 2010 | $0.00 | $0.00 | $0.00 | $0.98 | $0.98 | -34.2% |
| 2011 | $0.00 | $0.00 | $0.00 | $1.05 | $1.05 | 7.1% |
| 2012 | $0.00 | $0.00 | $0.00 | $1.20 | $1.20 | 14.3% |
| 2013 | $0.00 | $0.00 | $0.00 | $1.14 | $1.14 | -5.0% |
| 2014 | $0.00 | $0.00 | $0.00 | $1.29 | $1.29 | 13.2% |
| 2015 | $0.00 | $0.00 | $1.14 | $0.48 | $1.62 | 25.6% |
| 2016 | $0.40 | $0.43 | $0.50 | $0.52 | $1.84 | 13.6% |
| 2017 | $0.44 | $0.50 | $0.52 | $0.57 | $2.02 | 9.8% |
| 2018 | $0.39 | $0.63 | $0.58 | $0.63 | $2.22 | 9.9% |
| 2019 | $1.11 | $1.16 | $0.63 | $0.72 | $3.62 | 63.1% |
| 2020 | $0.45 | $0.76 | $0.63 | $0.88 | $2.71 | -25.1% |
| 2021 | $0.64 | $0.70 | $0.89 | $0.82 | $3.04 | 12.2% |
| 2022 | 0.7220 | 0.772900 | $0.82140 | $0.97960 | $2.5230 | -17.0% |
| 2023 | $0.7586 |
ぐりっと今回の発表は、この部分です。
まとめ
・VHTの2023年Q1は5.07％と増配。
・2023年Q1ではVHT投資は安定感はあるがインデックス投資が優位な結果。
・現状ではVT・VOOに投資する方が成果につながりやすいか。
雑談（サラリーマン投資家ぐりっと目線）
セクター別ETFでは唯一購入している銘柄。
数年前に1株購入しており経過を観察中。
売却予定はないが、購入予定はありません。
さらに下がるのであれば、長期的には購入も検討します。
投資は、投資家が自己の責任で行う行為であることを忘れてはなりません。投資には、市場の変動やリスクが伴います。そのため、投資家は自己責任に基づいて、リスクを認識し、投資に関する情報を十分に収集して判断する必要があります。また、投資に関する決定は、投資家自身が行い、その結果に対する責任も負わなければなりません。投資家は、自己の投資目的やリスク許容度を考慮し、自己の資金を適切に管理する必要があります。投資は、将来の利益を得ることができる可能性がありますが、一方で損失を被る可能性もあります。そのため、投資家は自己責任に基づいて投資を行い、損失を最小限に抑えるために十分な注意を払うことが重要です。
関連記事：あわせて読みたい
バフェットがいうとおり、投資には三振はありません。
必ずしもバッターボックスに立たないといけないわけではありません。
ただしバッターボックスで立つ準備をしている人と準備をしていない人では大きな差がでます。
投資口座を開設していない人は、準備だけでも進めていきましょう。
あわせて読みたい
2023年Q1のVYM配当：2023年以降も高配当ETFのトップランナーか？ 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VYMの2023年Q1（3月）の配当が発表されました。 2023年Q1…
あわせて読みたい
【2023年3月】一目でわかる!!サラ投資ブロガー ぐりっと金融資産 このブログでは毎月1日に金融資産を公開しています。 今回は2023年3月1日時点の金融資産です。 なぜ金融資産を公開するの？ 金融資産を公開する理由は2点あります。 1&#…
コメント